The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

被引：12

作者：

Lorand-Metze, I. ^{[1
]}

Califani, S. M. V. ^{[1
]}

Ribeiro, E. ^{[1
]}

Lima, C. S. P. ^{[1
]}

Metze, K. ^{[1
]}

机构：

[1] Univ Estadual Campinas, Fac Med, BR-13081970 Campinas, SP, Brazil

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 02期

基金：

巴西圣保罗研究基金会;

关键词：

myelodysplastic syndromes; cell maturation; phenotypic aberrations; flow cytometry; prognosis;

D O I：

10.1016/j.leukres.2007.06.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD13 on mature neutrophils, only hyperexpression of CD13 and degree of thrombocytopenia were independent risk factors. Therefore, phenotypic features that can also be obtained from PB might be useful for predicting Survival in MDS. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：211 / 213

页数：3

共 50 条

[41] Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion [J].

Huang, Xinhui ;

Li, Xiao ;

Liu, Qi ;

Guo, Juan ;

Chen, Jianan ;

Zhou, Liyu ;

Song, Luxi ;

Zhang, Zheng ;

Su, Jiying ;

Zhang, Yumei ;

Yan, Meng ;

He, Qi ;

Wu, Dong ;

Xu, Feng ;

Chang, Chunkang ;

Wu, Lingyun .

CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)

[42] The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes [J].

Reis-Alves, S. C. ;

Traina, F. ;

Saad, S. T. O. ;

Metze, K. ;

Lorand-Metze, I. .

NEOPLASMA, 2010, 57 (06) :530-536

[43] The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion [J].

Sophie Park ;

Charikleia Kelaidi ;

Mathieu Meunier ;

Nicole Casadevall ;

Aaron T. Gerds ;

Uwe Platzbecker .

Annals of Hematology, 2020, 99 :7-19

[44] Immunologic abnormalities in myelodysplastic syndromes - Clinical features and characteristics of the lymphoid population [J].

Matisavljevic, Dragomir ;

Kragujac, Nada ;

Rolovic, Zoran .

MEDICAL ONCOLOGY, 2006, 23 (03) :385-391

[45] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES - ANALYSIS OF 5 SCORING SYSTEMS [J].

RUBIOFELIX, D ;

GIRALDO, P ;

FRANCO, E ;

GIMENO, J ;

GIRALT, M .

HEMATOLOGICAL ONCOLOGY, 1995, 13 (03) :139-152

[46] Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes [J].

Ding, Kai ;

Fu, Rong ;

Liu, Hui ;

Nachnani, Deepak Anil ;

Shao, Zong-Hong .

ONCOLOGY LETTERS, 2016, 11 (04) :2347-2352

[47] Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome [J].

Sanchez-Castro, Judit ;

Marco-Betes, Victor ;

Gomez-Arbones, Xavier ;

Arenillas, Leonor ;

Valcarcel, David ;

Vallespi, Teresa ;

Costa, Dolors ;

Nomdedeu, Benet ;

Jose Jimenez, Maria ;

Granada, Isabel ;

Grau, Javier ;

Ardanaz, Maria T. ;

de la Serna, Javier ;

Carbonell, Felix ;

Cervera, Jose ;

Sierra, Adriana ;

Luno, Elisa ;

Cervero, Carlos J. ;

Falantes, Jose ;

Calasanz, Maria J. ;

Gonzalez-Porras, Jose R. ;

Bailen, Alicia ;

Luz Amigo, M. ;

Sanz, Guillermo ;

Sole, Francesc .

LEUKEMIA RESEARCH, 2013, 37 (07) :769-776

[48] Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes [J].

Saumell, Silvia ;

Fernandez-Serrano, Miranda ;

Mesa, Alba ;

Lopez-Cadenas, Felix ;

Arenillas, Leonor ;

Alfonso, Ana ;

Julia Montoro, Maria ;

Molero, Antonieta ;

Leoz, Pilar ;

Riego, Victoria ;

Gallur, Laura ;

Salamero, Olga ;

Navarrete, Mayda ;

Tazon-Vega, Barbara ;

Ortega, Margarita ;

Reig, Oscar ;

Roue, Gael ;

Calvo, Xavier ;

Prosper, Felipe ;

Diez-Campelo, Maria ;

Valcarcel, David .

LEUKEMIA & LYMPHOMA, 2022, 63 (05) :1227-1235

[49] Prognostic Classification and Risk Assessment in Myelodysplastic Syndromes [J].

Cazzola, Mario ;

Malcovati, Luca .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) :459-+

[50] Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes [J].

Cilloni, Daniela ;

Messa, Emanuela ;

Messa, Francesca ;

Carturan, Sonia ;

Defilippi, Ilaria ;

Arruga, Francesca ;

Rosso, Valentina ;

Catalano, Renata ;

Bracco, Enrico ;

Nicoli, Paolo ;

Saglio, Giuseppe .

ESTROGENS AND HUMAN DISEASES, 2006, 1089 :411-423

← 1 2 3 4 5 →